European Journal of Molecular & Clinical Medicine

Background:  Sclerotherapy and endovenous laser ablation (EVLA) have emerged as alternative treatments to surgery for patients with varicose veins, but uncertainty exists regarding their effectiveness in the medium to longer term.
Objectives: To compare the clinical effectiveness, outcome, complications, recurrence and post operative improvement in CEAP classification in patients treated with EVLA and Sclerotherapy .
Methods: This is a prospective study. All patients fulfilling inclusion criteria with varicose veins  in Krishna Hospital & Medical Research Centre, Karad will be included in the study
Results:  More than 80% of the study population was classified as C2 or C3 venous disease. After 1 and 1/2  year, the anatomic success rate was highest after EVLA , followed by sclerotherapy. The complication rate was low and comparable between treatment groups. All groups showed significant (P < .001) improvement of quality of life and Chronic Venous Insufficiency  72.10%  of patients with  C2 class showed an improvement of the "C" of the CEAP classification.
Conclusion: Endovenous ablation therapy has shown high improvement with the outcomes such as hospital stay, or post operative complications.It can be concluded that the endovenous ablation therapy is an effective method to cure varicose vein which taken significantly higher time for complication of the wound.Compared to sclerotherapy, and apart from signs and symptoms endovenous ablation therapy is an effective therapy which should be used in the management of varicose veins.

Varicose veins are veins that have become enlarged and tortuous. The term commonly refers to the veins on the leg. Endovenous laser therapy (EVLT) is a popular treatment for varicose veins. The study aimed to assess improvement the occlusion rate in the treatment of patients with varicose veins. Patients and methods: this study involved 18 patients with lower limb varicose veins presented at Zagazig University Hospital. All patients were examined clinically to identify symptoms and signs related to venous diseases and duplex ultrasonography were performed. Evaluation was done after one week, one month, 2 months and 3 months following treatment. Results: All patients had improvement in VCSS after EVLA during the first, second and third follow up visits when compared with preoperative scores. The VCSS ranged from 5 to 15 before the procedure, with a mean of 8.89, ranged from 1 to 6 at the first follow up visit with a mean of 3.4, ranged from 1 to 5 at the second follow up visit with a mean of 2.5 and ranged from 0 to 4 at the third follow up visit with a mean of 1.6. CIVIQ in the legs of studied group: Pre-operative was14.42 ± 7.29 while after 6 month was 7.64 ± 4.62. Only Ecchymosis in 2 limbs (6%), Paresthesia at leg in 3 limbs (9%), Phlebitis 4 limbs (12%),Skin burn in one limb (3%)and Incomplete occlusion in one patient(4%). Conclusion: Higher energy EVLA of varicose veins showed faster recovery attributable to the decreased pain, immediate ambulation and faster return to everyday activities. Patients experienced symptom relief after the procedure with decrease the VCSS and CIVIQ in both.